| Cardiovascular Risk Management |
1 |
1 |
| Lipids Management |
0 |
0.9 |
| Statins |
0 |
0.77 |
| Acute Coronary Syndrome |
0 |
0.34 |
| Coronary Artery Disease (CAD) |
0 |
0.34 |
| Heart Failure (HF) |
0 |
0.34 |
| Atherosclerosis |
0 |
0.33 |
| Patient Safety |
0 |
0.31 |
| Coronary Atherosclerosis |
0 |
0.27 |
| Adverse Effects |
0 |
0.24 |
| Cardiovascular disease |
0 |
0.24 |
| Renal Disease |
0 |
0.24 |
| Heart |
0 |
0.19 |
| Kidney |
0 |
0.19 |
| Biomarker |
0 |
0.14 |
| Hospital |
0 |
0.14 |
| Drug Interaction |
0 |
0.1 |
| Gout |
0 |
0.1 |
| Infarction |
0 |
0.1 |
| Myocardial Infarction (MI) |
0 |
0.1 |
| Polypharmacy |
0 |
0.1 |
| Spine |
0 |
0.1 |
| Obesity |
0 |
0.08 |
| Liver Disease |
0 |
0.07 |